Generalized Myasthenia Gravis Symptom Severity Reduced Through Ravulizumab Treatment
The highest proportions of patients with severe ocular impairment at baseline showed greater improvements in symptom severity on ravulizumab in comparison with placebo after 26 weeks.
Source: ajmc.com